Showing results (2101-2110 of 3,155) with videos related to
Sort By:
Pageof 316
Breast Cancer Research and Treatment|February 2, 2015
Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosisJian Wen, Syn Yeo, Chenran Wang, et al.Engineering in Life Sciences|March 6, 2023
Risk control of host cell proteins in one therapeutic antibody produced by concentrated fed-batch (CFB) modeYiling Lu, Jun Lin, Tianze Bian, et al.Applied Biochemistry and Biotechnology|March 23, 2023
CDK12 Promotes the Proliferation, Migration, and Angiogenesis of Gastric Carcinoma via Activating the PI3K/AKT/mTOR Signaling PathwayLi-Zhen Gao, Jun-Qing Wang, Jun-Lin Chen, et al.Nano Letters|December 11, 2025
Achieving Efficient Sonopiezoelectric Therapy for Tumor through Electron Spin Modulation via the Chiral-Induced Spin Selectivity EffectJie Ma, Ziyong Cheng, Meng Yuan, et al.Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|October 9, 2025
[Correlation analysis of clinical features between wet and dry gangrene in diabetic foot]Yu-Zhen Wang, Cheng-Lin Jia, Yong-Kang Zhang, et al.Angewandte Chemie (International Ed. in English)|February 6, 2024
Defect-Repaired g-C3N4 Nanosheets: Elevating the Efficacy of Sonodynamic Cancer Therapy Through Enhanced Charge Carrier MigrationZhuang Yang, Meng Yuan, Ziyong Cheng, et al.Small Methods|March 10, 2024
Defect-Engineered Tin Disulfide Nanocarriers as "Precision-Guided Projectile" for Intensive Synergistic TherapyYanlin Zhu, Ruoxi Zhao, Lili Feng, et al.Advanced Materials (Deerfield Beach, Fla.)|May 4, 2024
A Vacancy-Engineering Ferroelectric Nanomedicine for Cuproptosis/Apoptosis Co-Activated ImmunotherapyYaqian Du, Xudong Zhao, Fei He, et al.Journal of Orthopaedic Surgery and Research|May 19, 2026
Tibial periosteal distraction as an adjunct to percutaneous transluminal angioplasty for diabetic foot ulcers complicated by peripheral arterial disease/chronic limb-threatening ischemia: a retrospective cohort studyJun Lin, Shenggui Xu, Zhenbao Lu, et al.Pharmaceutics|June 24, 2022
Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer TreatmentHung-Jun Lin, Tien-Li Liang, Yao-Yuan Chang, et al.Pageof 316